Larvol Delta - PACIFIC8-A-Global-Study-to-Assess-the-Effects-of-Durvalumab--Domvanalimab-Following-Concurrent-Chemoradiation-in-Participants-With-Stage-III-Unresectable-NSCLC

Imfinzi (durvalumab) - AstraZeneca

domvanalimab (AB154) - Arcus Biosciences, Gilead

http://clinicaltrials.gov/ct2/show/NCT05211895

Aug 29, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next